The U.S. Consumer Product Safety Commission (CPSC) has warned consumers about using Doraemon Dovfun Suit Magnetic Ball Sets. It has come to light that these products contain loose magnets that pose a significant risk to individuals, especially children.
Reuters reported that seven deaths have already occurred as a result of ingestion.
Non-Compliance With Safety Regulations
According to PR Newswire, CPSC testing has revealed that the magnetic ball sets do not meet the requirements set forth by federal toy regulations. One or more magnets in the sets exceed the permissible strength, and these magnets are of a size that can easily fit within the small parts cylinder as defined by CPSC guidelines.
Potential Dangers and Consequences
After ingestion, the ingested magnets can attract to each other or other metal objects within the digestive system. This can lead to various complications, such as perforations, twisting, blockage of the intestines, infection, blood poisoning, and, in severe cases, death. It is estimated that from 2017 to 2021, approximately 2,400 magnet ingestions were treated in hospital emergency departments in the United States alone.
Inaction From the Seller
Despite a Notice of Violation issued to Doraemon, the Chinese seller of these magnetic ball sets, no action has been taken to address the issue. There is no recall of the product or offer of a remedy to consumers. This lack of response from Doraemon is concerning and raises further alarm about the safety of their products.
The magnetic ball sets were sold online at Amazon.com and were priced at around $25. Each set consisted of multi-colored magnetic balls arranged in a cube shape. These sets were sold encased in a clear plastic case and packaged in a portable tin storage box.
In light of these findings, CPSC urges consumers to cease using the Magnetic Ball Sets immediately, keep them out of reach of children, and properly dispose of them. The risk posed by these hazardous magnets is too high to ignore, and swift action is necessary to prevent further harm.
The Need for Enhanced Safety Measures
The CPSC remains committed to ensuring the safety of consumers and will continue to monitor the situation closely. Furthermore, manufacturers and sellers must prioritize compliance and adherence to safety regulations to protect consumers, particularly vulnerable populations like children.
Photo: PR Newswire


Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 



